127 related articles for article (PubMed ID: 24836184)
1. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
2. 4210 Da and 1866 Da polypeptides as potential biomarkers of liver disease progression in hepatitis B virus patients.
Ren Y; Yang L; Li M; Wang J; Yan H; Ma N; Liu W; Wang L; Gao X; Gao P; Li T; Liu D
Sci Rep; 2021 Aug; 11(1):16982. PubMed ID: 34417517
[TBL] [Abstract][Full Text] [Related]
3. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
Cai X; Peng S; Xiao X; Huang Z; Zhang P
Sci Rep; 2024 May; 14(1):10996. PubMed ID: 38744926
[TBL] [Abstract][Full Text] [Related]
4. Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases.
Miao X; Peng C; Yan F; Guo X; Xia L; Song Q; An X; Wu G
J Infect Dev Ctries; 2024 Apr; 18(4):618-626. PubMed ID: 38728647
[TBL] [Abstract][Full Text] [Related]
5. Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Shen Y; Chen J; Wu J; Li T; Yi C; Wang K; Wang P; Sun C; Ye H
Cancer Prev Res (Phila); 2024 May; 17(5):227-235. PubMed ID: 38489403
[TBL] [Abstract][Full Text] [Related]
6. Serum Ribonucleotide Reductase Subunit M2 in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma.
Jin X; Yu W; Wang A; Qiu Y
Lab Med; 2023 Nov; 54(6):626-632. PubMed ID: 36944169
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation of glycine dehydrogenase promoter in peripheral blood mononuclear cells is a new diagnostic marker of hepatitis B virus-associated hepatocellular carcinoma.
Miao LL; Wang JW; Liu HH; Gao S; Fan YC; Wang K
Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):35-42. PubMed ID: 36878837
[TBL] [Abstract][Full Text] [Related]
8. Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.
Han SX; Wang JL; Guo XJ; He CC; Ying X; Ma JL; Zhang YY; Zhao Q; Zhu Q
J Immunol Res; 2014; 2014():262385. PubMed ID: 24860834
[TBL] [Abstract][Full Text] [Related]
9. Decreased GPX3 mRNA level in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma.
Han LY; Sun WJ; Zhao ZH; Gao S; Wang K
Trans R Soc Trop Med Hyg; 2023 Oct; 117(10):727-732. PubMed ID: 37310002
[TBL] [Abstract][Full Text] [Related]
10. N-glycopeptide Signatures of IgA
Zhang S; Cao X; Liu C; Li W; Zeng W; Li B; Chi H; Liu M; Qin X; Tang L; Yan G; Ge Z; Liu Y; Gao Q; Lu H
Mol Cell Proteomics; 2019 Nov; 18(11):2262-2272. PubMed ID: 31501225
[TBL] [Abstract][Full Text] [Related]
11. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Dengler M; Staufer K; Huber H; Stauber R; Bantel H; Weiss KH; Starlinger P; Pock H; Klöters-Plachky P; Gotthardt DN; Rauch P; Lackner C; Stift J; Brostjan C; Gruenberger T; Kumada T; Toyoda H; Tada T; Weiss TS; Trauner M; Mikulits W
Oncotarget; 2017 Jul; 8(28):46234-46248. PubMed ID: 28526812
[TBL] [Abstract][Full Text] [Related]
12. Serum heat shock protein 27 levels in patients with hepatocellular carcinoma.
Gruden G; Carucci P; Lolli V; Cosso L; Dellavalle E; Rolle E; Cantamessa A; Pinach S; Abate ML; Campra D; Brunello F; Bruno G; Rizzetto M; Perin PC
Cell Stress Chaperones; 2013 Mar; 18(2):235-41. PubMed ID: 23073653
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a diagnostic model for AFP-negative hepatocellular carcinoma.
Yu Z; Chen D; Zheng Y; Wang X; Huang S; Lin T; Lin Y; Zhang Y; Huang Y; Ou Q; Huang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11295-11308. PubMed ID: 37368120
[TBL] [Abstract][Full Text] [Related]
14. Serum Expression Level of MicroRNA-122 and Its Significance in Patients with Hepatitis B Virus Infection.
Fang Q; Chen W; Jian Y; Li Y; Lian W; Wan H; Chen S; Li F; Chen Y
J Healthc Eng; 2022; 2022():8430276. PubMed ID: 35251580
[TBL] [Abstract][Full Text] [Related]
15. SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma.
Zhang Y; Lao W; Yang K; Kong X; Li Y; Yu X; Wang X; Liu Y; Li Z; Deng Y; Nie S; Bi C; Wu C; Zhai A
BMC Cancer; 2023 Nov; 23(1):1159. PubMed ID: 38017386
[TBL] [Abstract][Full Text] [Related]
16. Screening for Hepatocellular Carcinoma in Patients with Hepatitis B.
Sachar Y; Brahmania M; Dhanasekaran R; Congly SE
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372524
[TBL] [Abstract][Full Text] [Related]
17. Significance of Serum Adiponectin and Insulin Resistance Levels in Diagnosis of Egyptian Patients with Chronic Liver Disease and HCC.
Radwan HA; Hamed EH; Saleh OM
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1833-1839. PubMed ID: 31244307
[TBL] [Abstract][Full Text] [Related]
18. [Fonction de l'ARNnc exosomal HEIH dans le carcinome hépatocellulaire associé au virus de l'hépatite B].
Yu T; Li H; Shen G; Wu Q
Ann Biol Clin (Paris); 2024 Apr; 82(1):93-102. PubMed ID: 38638022
[TBL] [Abstract][Full Text] [Related]
19. Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma.
Zhang X; Li W; Li S; Zhang Z; Song W
Virus Genes; 2024 Apr; ():. PubMed ID: 38568442
[TBL] [Abstract][Full Text] [Related]
20. New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology.
Zhu XD; Zhang WH; Li CL; Xu Y; Liang WJ; Tien P
World J Gastroenterol; 2004 Aug; 10(16):2327-9. PubMed ID: 15285013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
